Brasher B B, Roumiantsev S, Van Etten R A
Enanta Pharmaceuticals, 500 Arsenal Street, Watertown, MA 02472, USA.
Oncogene. 2001 Nov 22;20(53):7744-52. doi: 10.1038/sj.onc.1204978.
The catalytic activity of the c-Abl tyrosine kinase is tightly regulated by its Src homology 3 (SH3) domain through a complex mechanism that may involve intramolecular binding to Pro242 in the linker region between the SH2 and catalytic domains as well as interactions with a trans-inhibitor. We analysed the effect of mutation or replacement of SH3 on c-Abl tyrosine kinase activity and transformation. Random mutagenesis of SH3 identified several novel point mutations that dysregulated c-Abl kinase activity in vivo, but the RT loop was insensitive to mutational activation. Activating SH3 mutations abolished binding of proline-rich SH3 ligands in vitro, while mutations at Ser140 in the connector between the SH3 and SH2 domains activated Abl kinase activity in vivo and in vitro but did not impair SH3 ligand-binding. Abl was regulated efficiently when its SH3 domain was replaced with a heterologous SH3 from c-Src that binds a different spectrum of proline-rich ligands, but not by substitution of a modular WW domain with similar ligand-binding specificity. These results suggest that the SH3 domain regulates Abl principally by binding to the atypical intramolecular ligand Pro242 rather than a canonical PxxP ligand. Coordination between the SH3 and SH2 domains mediated by the connector region may be required for regulation of Abl even in the absence of SH2 ligand binding.
c-Abl酪氨酸激酶的催化活性通过一种复杂机制受到其Src同源3(SH3)结构域的严格调控,该机制可能涉及分子内与SH2和催化结构域之间连接区的Pro242结合以及与反式抑制剂的相互作用。我们分析了SH3的突变或替换对c-Abl酪氨酸激酶活性和转化的影响。SH3的随机诱变鉴定出几个在体内使c-Abl激酶活性失调的新的点突变,但RT环对突变激活不敏感。激活SH3突变在体外消除了富含脯氨酸的SH3配体的结合,而SH3和SH2结构域之间连接区的Ser140突变在体内和体外激活了Abl激酶活性,但不损害SH3配体结合。当用来自c-Src的异源SH3替换其SH3结构域时,Abl受到有效调控,该异源SH3结合不同谱的富含脯氨酸的配体,但用具有相似配体结合特异性的模块化WW结构域替换则不能。这些结果表明,SH3结构域主要通过与非典型分子内配体Pro242结合而非经典的PxxP配体来调节Abl。即使在没有SH2配体结合的情况下,连接区介导的SH3和SH2结构域之间的协调对于Abl的调节可能也是必需的。